These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10832825)

  • 1. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group.
    Boden WE; Scheldewaert R; Walters EG; Whitehead A; Coltart DJ; Santoni JP; Belgrave G; Starkey IR
    Am J Cardiol; 1995 Jun; 75(16):1120-3. PubMed ID: 7762497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers?
    Boden WE
    Drugs; 1996; 52 Suppl 4():20-30. PubMed ID: 8913715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial.
    Théroux P; Grégoire J; Chin C; Pelletier G; de Guise P; Juneau M
    J Am Coll Cardiol; 1998 Sep; 32(3):620-8. PubMed ID: 9741502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of acute non-Q-wave myocardial infarction. The role of prophylactic diltiazem therapy and indications for predischarge coronary arteriography.
    Gibson RS
    Drugs; 1991; 42 Suppl 2():28-37. PubMed ID: 1718699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
    Roberts R
    Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R
    Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists in the post-myocardial infarction setting.
    Bertolet BD
    Drugs Aging; 1999 Dec; 15(6):461-70. PubMed ID: 10641957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group.
    Boden WE; Krone RJ; Kleiger RE; Oakes D; Greenberg H; Dwyer EJ; Miller JP; Abrams J; Coromilas J; Goldstein R
    Am J Cardiol; 1991 Feb; 67(5):335-42. PubMed ID: 1994656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
    Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
    N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.
    Wong SC; Greenberg H; Hager WD; Dwyer EM
    J Am Coll Cardiol; 1992 Jun; 19(7):1421-5. PubMed ID: 1593034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
    Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE
    Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
    Cucherat M; Bonnefoy E; Tremeau G
    Cochrane Database Syst Rev; 2000; (2):CD001560. PubMed ID: 10796812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.